Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesVisioneering Technologies Inc

Visioneering Technologies Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
None AUD 0.00(0%)
Last update at 2025-02-27T06:23:59.449345Z
Market Cap
3.70M

Momentum Score

…

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.04
Low
0.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.07
Dividend Yield
-
Revenue TTM
8.64M
Revenue Per Share
0.19
Gross Profit TTM
2.67M
Debt / Equity
0.19
ROE
-77.67%
Net Debt
-0.37M
ROCE
-71.95%
Diluted EPS TTM
-0.12

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -5.85M -2.33M -9.24M -12.61M -16.73M
Net income -5.85M -2.33M -9.24M -12.62M -16.73M
Selling general administrative 2.42M 3.19M 3.32M 3.39M 4.08M
Selling and marketing expenses 3.64M 4.90M 5.18M 9.15M 10.13M
Gross profit 3.32M 2.97M 2.22M 1.97M -0.08M
Reconciled depreciation 0.02M 0.03M 0.05M 0.07M 0.08M
Ebit -5.55M -2.01M -8.04M -12.73M -16.73M
Ebitda -5.53M -1.98M -8.85M -12.38M -16.66M
Depreciation and amortization 0.02M 0.03M -0.81M 0.35M 0.08M
Operating income -5.55M -2.01M -8.04M -12.73M -16.99M
Other operating expenses 13.11M 14.45M 12.87M 18.45M 20.28M
Interest expense 0.30M 0.32M 0.33M 0.16M 0.00M
Tax provision 0.01M 0.01M 0.00M 0.01M 0.00M
Interest income 0.07M 4.02M 0.01M 0.05M 0.18M
Net interest income -0.22M -0.32M -0.42M -0.11M 0.26M
Extraordinary items - - - - 0.00M
Income tax expense 0.01M 0.01M 0.00M 0.01M 0.00M
Total revenue 7.29M 7.15M 5.11M 5.72M 3.29M
Total operating expenses 9.14M 10.26M 9.99M 14.69M 16.91M
Cost of revenue 3.97M 4.19M 2.88M 3.75M 3.37M
Total other income expense net -0.30M -0.32M -1.20M 0.12M 0.26M
Net income from continuing ops -5.85M -2.33M -12.00M -18.01M -23.71M
Net income applicable to common shares -5.85M -2.33M -9.24M -12.62M -16.73M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets - 9.11M 14.91M 4.99M 5.83M
Intangible assets - 0.15M 0.16M 0.18M 0.15M
Other current assets -4.40M 0.96M 1.15M 0.52M 0.20M
Total liab - 2.81M 4.87M 6.69M 4.85M
Total stockholder equity - 6.29M 10.04M -1.71M 0.98M
Other current liab - 1.03M 1.58M 2.38M 1.50M
Common stock - 95.31M 93.20M 79.12M 72.57M
Capital stock - 95.31M 93.20M 79.12M 72.57M
Retained earnings - -89.01M -83.16M -80.82M -71.58M
Other liab - 0.17M 0.01M - 0.21M
Other assets - 0.21M 0.20M 0.18M 0.20M
Cash 0.37M 3.12M 10.98M 2.41M 1.92M
Cash and equivalents - 3.12M 10.98M 2.41M 1.92M
Total current liabilities - 1.39M 2.12M 2.71M 1.78M
Net debt -0.37M -1.91M -8.24M 0.42M 0.94M
Short term debt - 0.00M 0.00M 0.00M 0.00M
Short long term debt total - 1.21M 2.74M 2.83M 2.86M
Other stockholder equity - - - - 0.24M
Property plant equipment - 0.26M 0.11M 0.21M 0.32M
Total current assets - 8.49M 14.45M 4.42M 5.16M
Net tangible assets - 6.15M 9.88M -1.88M 0.83M
Short term investments 4.03M 1.84M - - -
Net receivables - 0.73M 0.91M 0.94M 0.83M
Long term debt - 1.21M 2.74M 3.67M 2.86M
Inventory - 1.86M 1.41M 0.55M 2.21M
Accounts payable - 0.36M 0.54M 0.33M 0.28M
Accumulated other comprehensive income - - - - -0.24M
Common stock total equity - - - 102.72M 103.58M
Non currrent assets other - 0.21M 0.20M 0.18M 0.20M
Non current assets total - 0.61M 0.47M 0.56M 0.67M
Long term debt total - 1.21M 2.74M 3.87M 2.86M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.84M -0.02M -0.03M -0.00M -0.02M
Change to liabilities -0.19M 0.21M 0.05M 0.14M -0.02M
Total cashflows from investing activities -1.84M -0.02M -0.02M -0.00M -0.02M
Net borrowings -0.04M -0.07M 1.03M 3.00M 3.00M
Total cash from financing activities -0.04M 16.60M 7.02M 7.30M 8.86M
Change to operating activities 0.10M -0.13M -1.07M 0.09M 0.40M
Net income -5.85M -2.33M -9.24M -12.62M -16.73M
Change in cash -7.87M 8.58M 0.49M -5.36M -13.19M
Begin period cash flow 10.98M 2.41M 1.92M 7.28M 23.50M
End period cash flow 3.12M 10.98M 2.41M 1.92M 10.31M
Total cash from operating activities -5.83M 0.03M -6.51M -12.65M -15.55M
Issuance of capital stock - 16.67M 5.70M 4.33M 6.25M
Depreciation 0.02M 0.03M 0.05M 0.07M 0.08M
Other cashflows from investing activities -1.84M 0.00M - 0.00M -0.01M
Change to inventory -0.45M -0.86M 1.66M -0.19M -0.10M
Change to account receivables 0.18M 0.04M -0.11M -0.34M -0.25M
Sale purchase of stock 0.00M 16.67M 5.99M 4.33M 6.25M
Other cashflows from financing activities -1.84M -0.02M 1.32M 2.96M -22.03M
Change to netincome 0.06M -5.08M 2.03M 0.18M 1.08M
Capital expenditures 0.00M 0.02M 0.02M 0.00M 0.02M
Change in working capital -0.36M -0.74M 0.53M -0.30M 0.03M
Other non cash items 5.83M 2.31M 9.19M 12.55M 16.66M
Free cash flow -5.83M -0.02M -0.02M -0.00M -22.05M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COH
Cochlear Ltd		 -3.47
2.23%		 152.00 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc		 -0.01
0.39%		 1.27 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp		 0.05
0.61%		 8.25 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc		 0.34
7.47%		 4.89 - 9.97 9.59 7.17 6.76 15.37

Profile*

Visioneering Technologies Inc

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

30 Mansell Court, Alpharetta, GA, United States, 30076

844 884 5367

https://www.vtivision.com

Name Title Year Born
Mr. Brian D. Lane CPA Chief Operating & Chief Financial Officer 1962
Mr. Tony Sommer Jr. Sr. VP of Sales & Marketing NA
Dr. Kuang-Mon Tuan FAAO, Ph.D. Chief Medical Officer NA
Dr. Richard A. Griffin Founder & Medical Adviser NA
Ms. Layna L. Mendlinger Global Head of Marketing NA
Ms. Leanne Ralph AAICD, ACIS, BBus Company Sec. NA
Dr. Douglas P. Benoit OD, FAAO Exec. Director of Professional Affairs NA
Dr. Juan Carlos Aragon CEO & Executive Director NA
Ms. Leanne Ralph AAICD, ACIS, BBus Company Secretary NA
Dr. Juan Carlos Aragon CEO & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…